Gene therapy, a revolutionary approach to treating and preventing diseases by modifying faulty genes, relies heavily on accurate measurement techniques. Ensuring the safety and efficacy of these treatments necessitates precise quantification of adeno-associated virus (AAV) vectors, which deliver
Glioblastoma multiforme, an aggressive form of brain cancer, has long been a formidable challenge in the medical field. With patient survival rates stagnating around 15 to 18 months, the need for innovative treatment approaches is critical. NeOnc Technologies, under the leadership of Dr. Thomas
The UK’s National Health Service (NHS) is grappling with significant challenges, including a critical backlog in diagnostic services and a shortage of specialist staff. These issues are leading to prolonged patient waiting times and inefficiencies in healthcare delivery. The NHS’s Long Term
Prostate cancer remains one of the most common cancers among men, and while hormone therapies have significantly improved patient outcomes, resistance to these treatments is a major challenge. The emergence of NXP800, a novel drug currently under clinical trials, offers a promising new approach to
Precision oncology is revolutionizing cancer treatment by tailoring medical care based on the genetic makeup of a patient's tumor. However, significant disparities exist in the effectiveness and availability of these treatments among patients of different ancestries. This article delves into the
The J.P. Morgan (JPM) Healthcare Conference marks the beginning of a new year for the healthcare industry, typically setting the tone for upcoming trends and innovations. Held annually at the Westin St. Francis in San Francisco, this prestigious event attracts a diverse group of stakeholders,
NEC Corporation and Biomy, Inc. have announced a groundbreaking partnership aimed at revolutionizing digital pathology through the integration of artificial intelligence (AI) and deep learning (DL). This collaboration, formalized in a recent Memorandum of Understanding (MoU), seeks to enhance
Groundbreaking research conducted by a collaborative team from Mount Sinai and Memorial Sloan Kettering Cancer Center has unveiled a novel mechanism by which monoamine neurotransmitters, specifically serotonin, dopamine, and histamine, regulate brain physiology and behavior. This research
The field of drug discovery has long been challenged by the concept of "undruggable" targets—proteins and pathways that are crucial in disease processes but difficult to target with traditional small molecule drugs. One particularly challenging target is β-catenin, a key player in the Wnt/β-catenin
Autoimmune diseases occur when the immune system erroneously targets the body's own cells and tissues. These diseases usually present a preclinical stage with mild symptoms or specific antibodies detectable in blood tests before the disease fully manifests. However, in some cases, these symptoms
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy